<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>stocks on FinanClub</title>
    <link>https://finan.club/tags/stocks/</link>
    <description>Recent content in stocks on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Wed, 27 Dec 2023 09:03:36 +0000</lastBuildDate><atom:link href="https://finan.club/tags/stocks/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>PATH</title>
      <link>https://finan.club/us/path/</link>
      <pubDate>Wed, 27 Dec 2023 09:03:36 +0000</pubDate>
      
      <guid>https://finan.club/us/path/</guid>
      <description>score:131
Chances: UiPath did an excellent job in 2023, accelerating revenue and controlling costs. Market catalysts and internal growth make it likely that these stocks will continue to rally in 2024. Each of these businesses experienced substantial year-over-year revenue growth. In this article, we discuss the 14 best automation stocks to buy now.</description>
    </item>
    
    <item>
      <title>AZN</title>
      <link>https://finan.club/us/azn/</link>
      <pubDate>Tue, 19 Dec 2023 09:06:54 +0000</pubDate>
      
      <guid>https://finan.club/us/azn/</guid>
      <description>score:-135
Chances: AstraZeneca (AZN) closed at $65.95, indicating a +1.77% shift from the previous trading day. AstraZeneca (AZN) announces that it is buying vaccine company, Icosavax. The additional supply of RSV shot for infants by AstraZeneca and Sanofi indicates a positive outlook for meeting winter demand.</description>
    </item>
    
  </channel>
</rss>
